![Remo Gujer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Remo Gujer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Celgene Ltd.
![]() Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Remo Gujer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CELGENE | Biotechnology | Comptroller/Controller/Auditor | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel | |
Foley & Lardner LLP
![]() Foley & Lardner LLP Miscellaneous Commercial ServicesCommercial Services Foley & Lardner LLP engages in the provision of legal services. Its practice areas include employee benefits and executive compensation, environmental, estates and trusts, finance, international tax and transfer pricing, private equity and venture capital, real estate, securities, commodities and exchange regulation, taxation, and transactions. The company was founded by Asahel Finch and William Pitt Lynde on September 8, 1842 and is headquartered in Milwaukee, WI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bunge Ltd.
![]() Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Comptroller/Controller/Auditor | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Brown University | College/University | Undergraduate Degree | |
Junior Achievement of New Jersey, Inc. | Director/Board Member | ||
Acetylon Pharmaceuticals, Inc.
![]() Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Celgene UK Manufacturing Ltd.
![]() Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Celgene UK Holdings Ltd.
![]() Celgene UK Holdings Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Yale Law School | College/University | Graduate Degree | |
JUNO THERAPEUTICS INC | Biotechnology | Treasurer | |
Delinea, Inc. (United States)
![]() Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Biotechnology | Chief Executive Officer | |
Celgene Europe Ltd.
![]() Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The company is based in Middlesex, UK. | Biotechnology | Director/Board Member Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Corporate Secretary | |
Celgene UK Manufacturing (II) Ltd.
![]() Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member Director/Board Member |
Statistics
International
United States | 14 |
United Kingdom | 5 |
Sectoral
Health Technology | 9 |
Finance | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Process Industries | 2 |
Operational
Director/Board Member | 12 |
Corporate Secretary | 5 |
General Counsel | 4 |
Corporate Officer/Principal | 3 |
Treasurer | 2 |
Most connected contacts
Insiders | |
---|---|
Jonathan Biller | 17 |
Jurg Oehen | 6 |
- Stock Market
- Insiders
- Remo Gujer
- Company connections